Human-steered next-generation machine learning for reviving drug design

Acronym

HEALED

Description of the granted funding

The aim of this project is to develop machine learning methods that enable reviving drug development, which has currently been significantly slowed down due to a huge increase of development cost. We develop new methods, with which drug design can take into account both the enlarging measurement databases and expertise of the drug developers. The methods will be general-purpose, and will be taken into use widely in other fields as well, in the Finnish Center for Artificial Intelligence FCAI where the research will be carried out.
Show more

Starting year

2021

End year

2025

Granted funding


Samuel Kaski
479 905 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
Aalto University (342077)
479 905 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

341763

Fields of science

Computer and information sciences

Research fields

Laskennallinen data-analyysi

Identified topics

bioinformatics